Power Up Your Brain
Power Up Your Brain
by David Perlmutter, MD, FACN, ABIHM &
Albert Villoldo, Ph.D
Raise a Smarter Child by Kindergarten
Raise a Smarter Child by Kindergarten
by David Perlmutter, MD, FACN, ABIHM
The Better Brain Book


by David Perlmutter, MD, FACN, ABIHM
Read Dr. Perlmutter's
articles at

Antidepressants: The right people aren’t always getting them

May 18th, 2009

The medications are widely used to treat complaints such as loneliness or low energy. Meanwhile, studies say many with depression go untreated

From LATimes.com:
It was just over 20 years ago that the antidepressant Prozac was first approved by the U.S. Food and Drug Administration. The medication was touted as nothing short of a miracle: Not only was it was highly effective in treating depression, it also caused very few side effects.

The drug’s popularity grew rapidly, and pharmaceutical companies got busy developing a variety of other, chemically similar antidepressants, collectively referred to as selective serotonin reuptake inhibitors (or SSRIs). There are at least half a dozen SSRIs on the market, including Lexapro, Paxil, Zoloft, Celexa and Luvox.

Since the introduction of these drugs, the number of Americans being treated for depression has increased dramatically; the Centers for Disease Control and Prevention says antidepressants are the most commonly prescribed medication in the country. But it’s not always the right people taking them. Some who probably have very little to gain from their use are on SSRIs; others who stand to benefit are not.

SSRIs work by increasing levels of the neurotransmitter serotonin in the brain and can effect miraculous — even lifesaving — improvements in men and women suffering from major depression. But use of these medications is not being restricted to individuals with clear-cut depression; they’re also being widely used to treat far milder complaints, such as loneliness or low energy.

“A lot of people are struggling with very difficult situations,” says Dr. Andrew Leuchter, professor in the department of psychiatry and biobehavioral sciences at UCLA. Financial problems, marital strife or the death of a loved one can send even the most stalwart into a tailspin.

But emotionally struggling or sad is not the same thing as depressed. Depression is not about feeling a bit blue; it’s a devastating disease that undermines one’s sense of self-worth and interferes with the ability to perform even routine activities.

To better understand the way in which antidepressants were being prescribed, researchers at the Rand Corp. in 2002 surveyed close to 700 adults who had received a prescription for an antidepressant. Of those who reported receiving the medication for depression, just 20% tested positive when screened for the disease. Fewer than 30% of those receiving the medication had any depressive symptoms at all.

According to some mental health experts, antidepressants probably aren’t particularly effective in treating mild depressive symptoms.

“They’re not in and of themselves mood elevators,” says Dr. Karen Swartz, director of clinical programs at the Johns Hopkins Mood Disorder Center. “People with basically ‘normal’ mood don’t feel happier when they’re on them.”

Others, however, defend their broader use.

“The evidence regarding who’s going to benefit from these medications and who won’t isn’t so clear-cut,” Leuchter says.

Unfortunately, it’s not easy to tease out which side is right. After starting these medications, people may feel better for reasons that have little to do with their antidepressant action. In some, the drug can produce a placebo effect (these individuals improve simply because they believe the medication is going to help them). In others, it may alleviate problems like anxiety or sleep difficulties, thus making the patient feel better.

Many psychiatrists seem relatively unconcerned about the potential overuse of antidepressants. Though they acknowledge that these drugs carry risks of side effects such as diminished sex drive, nausea and loss of appetite and could cost the patient several hundred dollars a year, they’re quick to point out that the danger of allowing depression to go untreated is far more serious.

Multiple studies have found that roughly half of all people with depression go untreated, and the vast majority in treatment aren’t adequately medicated. These individuals suffer emotionally, and thousands go on to commit suicide every year.

With the terrific medications that are available, that should not be happening. But treating lots of people unnecessarily to ensure that no one who could really benefit from medications is overlooked isn’t the answer.

Primary-care doctors, who dispense 80% of all antidepressant prescriptions, need better guidelines to help differentiate when treatment is indicated. Patients need to understand that antidepressants aren’t a cure-all. They won’t eliminate life’s ups and downs.

The drugs also won’t fundamentally change a person’s character. They can’t cure a pessimistic outlook or a bad attitude and won’t fill someone’s perpetually half-empty glass. To remedy things like that, people have to look well beyond the medicine cabinet.

Ulene is a board-certified specialist in preventive medicine practicing in Los Angeles. The M.D

Low vitamin D boosts depression risk in seniors

June 3rd, 2008

From News – Revolution Health

Older people with low blood levels of vitamin D and high blood levels of parathyroid hormone are more likely to be depressed, Dutch researchers report.

But it remains unclear whether these abnormalities are a cause or a consequence of depression, Dr. Witte J. G. Hoogendijk and colleagues from Vrije Universiteit in Amsterdam say.

Past studies have linked altered levels of vitamin D and parathyroid hormone with depression, but the relationship “has never been studied systematically,” Hoogendijk and colleagues note. To investigate, they looked at 1,282 men and women aged 65 to 95 years participating in a long-term study of aging.

Nearly 40 percent of the men and 57 percent of women had low levels of vitamin D in their blood.

Among the 169 people found by self-report and diagnostic interviews to be suffering from minor depression, as well as the 26 with major depressive disorder, vitamin D levels were 14 percent lower than for people who were free from depression, the researchers found.

And blood levels of parathyroid hormone, which increase with vitamin D deficiency, were 5 percent higher in people with minor depression and 33 percent higher in those with major depression, relative to levels seen in seniors without depression.

There are a number of plausible ways that low vitamin D levels could influence mood, the researchers note, given that the vitamin plays a role in several neurological and hormonal processes.

If vitamin D deficiency is a cause rather than a result of depression, they add, this suggests supplementation with the vitamin and increased exposure to sunlight could help treat the mood disorder.

Long-term studies with repeated assessments are needed to explore the question of whether decreased vitamin D levels and increased parathyroid hormone levels precede depression or follow it, the researchers conclude.

Relatives of Parkinson’s Patients at Higher Psychiatric Risk

January 4th, 2008

This suggests a link between the illness and depression, anxiety disorders, researchers say

From HealthScout

The close relatives of people with Parkinson’s disease are at increased risk for depression and anxiety disorders, new research suggests.

The risk is particularly high in the brothers, sisters, parents and children of people who develop Parkinson’s before age 75, said a team from the Mayo Clinic in Rochester, Minn.

The study included 1,000 immediate relatives of 162 Parkinson’s patients and 850 immediate relatives of 147 people without Parkinson’s. It’s the first large population-based study to identify this kind of association.

“Studies by our group and others have shown that relatives of patients with Parkinson’s disease have an increased risk of Parkinson’s disease. Recently, we showed they also have increased risk of essential tremor and of cognitive impairment or dementia. However, the risk of psychiatric disorders was unknown,” senior author Dr. Walter Rocca, a neurologist and epidemiologist, said in a prepared statement.

“Because many patients with Parkinson’s disease develop anxiety and depression after and even before the onset of the disease, we explored whether this tendency was present to a greater extent in family members of people with Parkinson’s disease compared with people without the disease. We found that, indeed, relatives of patients with Parkinson’s disease are at increased risk for anxiety and depressive disorders, which suggests a genetic or other relationship between those disorders and Parkinson’s disease,” Rocca said.

Further research is needed to determine the exact cause or causes that boost the risk, he said.

The study was published in the December issue of the journal Archives of General Psychiatry.

Blood Pressure Drug May Curb Brain Damage From Alzheimer’s, Depression And Schizophrenia

December 20th, 2007

From Sciencedaily.com

A drug used to treat high blood pressure and enlargement of the prostate may protect the brain from damage caused by post-traumatic stress disorder, Alzheimer’s disease, depression and schizophrenia.

Prazosin, also prescribed as an antipsychotic medication, appears to block the increase of steroid hormones known as glucocorticoids, Oregon Health & Science University and Portland Veterans Affairs Medical Center researchers have found. Elevated levels of glucocorticoids are associated with atrophy in nerve branches where impulses are transmitted, and even nerve cell death, in the hippocampus.

The hippocampus is the elongated ridge located in the cerebral cortex of the brain where emotions and memory are processed.

“It’s known, from human studies, that corticosteroids are not good for you cognitively,” said study co-author S. Paul Berger, M.D., assistant professor of psychiatry and behavioral neuroscience, OHSU School of Medicine and the PVAMC. “We think prazosin protects the brain from being damaged by excessive levels of corticosteroid stress hormones.”

The study, titled “Prazosin attenuates dexamethasone-induced HSP70 expression in the cortex,” is being presented during a poster session today at Neuroscience 2007, the annual Society for Neuroscience conference in San Diego.

Scientists believe stress activates a neurochemical response in the brain that triggers the release of glucocorticoids in the brain, and that high levels of glucocorticoids in blood serum are associated with such psychiatric conditions as schizophrenia, depression, PTSD and Alzheimer’s disease. This mechanism has been linked to decreases in cognitive performance in older people who are not suffering from clinical dementia.

“Our hypothesis is that just being afraid of being blown up all the time means you have high levels of steroids all the time,” Berger said, referring to PTSD among military personnel.

Low levels of glucocorticoids have anti-inflammatory effects in the brain, but high levels can trigger inflammatory mechanisms that damage nerve cells by activating an enzyme that causes oxidative stress. Even a single exposure to a high dose of glucocorticoids can be sufficient to damage nerve cells: A previous study showed synthetic glucocorticoid therapy to treat autoimmune disorders such as rheumatoid arthritis can induce mood disorders, including psychosis, and cognitive impairment known as “steroid dementia” in severe forms.

To determine the effects of prazosin, OHSU and PVAMC researchers, led by Altaf Darvesh, Ph.D., formerly of the OHSU Department of Psychiatry, administered a glucocorticoid called dexamethasone to rats, then measured the expression of a protein known as heat shock protein 70, or HSP70, that serves as a marker for neurotoxicity. Pretreatment with prazosin, an alpha-1 receptor antagonist, resulted in “significant” slowing of dexamethasone-induced expression in the cerebral cortex.

“The one thing we don’t know for sure is, would you have to get it before you’re traumatized,” Berger said. “Lots of people have high levels of corticosteroids when they’re under stress, so could we give them prazosin ahead of time to protect them from brain damage?”

Berger said future research will continue to look at where and how steroids cause brain damage, and just when prazosin would have to be administered to most effectively protect the brain against damage.

“We just looked at brain damage,” he said. “Steroids are known to cause cognitive impairment in both rats and people, so the next step is to see if we can correlate brain damage with cognitive effects and determine if we can protect against brain damage to protect cognition.”

Why I Treat Depression with Omega 3 Supplements

December 12th, 2007

Read entire citation here:Omega-3 fatty acids and major depression: A primer for the mental health professional

Abstract

Omega-3 fatty acids play a critical role in the development and function of the central nervous system. Emerging research is establishing an association between omega-3 fatty acids (alpha-linolenic, eicosapentaenoic, docosahexaenoic) and major depressive disorder. Evidence from epidemiological, laboratory and clinical studies suggest that dietary lipids and other associated nutritional factors may influence vulnerability and outcome in depressive disorders. Research in this area is growing at a rapid pace. The goal of this report is to integrate various branches of research in order to update mental health professionals.